Alpha DNA Investment Management’s Baker Hughes BKR Stock Holding History

Alpha DNA Investment Management’s Portfolio BKR Stock Details BKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,835	Closed	-$937K	–	31
2024 Q4	$937K	Sell	22,835 -242	-1%	-$9.76K	0.36%	55
2024 Q3	$834K	Sell	23,077 -4,421	-16%	-$155K	0.31%	70
2024 Q2	$967K	Buy	+27,498	New	+$902K	0.38%	54
2021 Q2	–	Sell	-239	Closed	-$5K	–	159
2021 Q1	$5K	Buy	+239	New	+$5.44K	0.01%	351

Other funds holding BKR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha DNA Investment Management's BKR Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Baker Hughes (BKR) in Q1 2025, closing a stake of 22,835 shares — an estimated $937K sold.

Alpha DNA Investment Management first reported a position in BKR in Q1 2021 and held it in 4 quarters. The position peaked at $967K in Q2 2024. 958 funds tracked by Wall St. Rank hold BKR as of Q1 2025.

Alpha DNA Investment Management reported no remaining Baker Hughes position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 22,835 Baker Hughes shares in Q1 2025, an estimated $937K.
Alpha DNA Investment Management first reported a position in Baker Hughes in Q1 2021 and held it in 4 quarters.
Alpha DNA Investment Management's Baker Hughes position peaked at $967K in Q2 2024.
958 funds tracked by Wall St. Rank held Baker Hughes as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.